OBJECTIVE: To study the effect of Tai Chi on exercise tolerance in patients with moderate heart failure. DESIGN: Randomised parallel group study balanced for baseline variables. SETTING: Cardiology Department, Royal Hallamshire Hospital. PATIENTS AND METHODS: 52 patients (42 men, mean age (68.9 years), range (46-90 years), and 10 women, mean age (70.0 years), range (58-82)) with chronic heart failure (New York Heart Association symptom class II-III) were studied. Patients were randomised to Tai Chi Chuan twice a week for 16 weeks or to standard medical care without exercise rehabilitation. MAIN OUTCOME MEASURES: The primary outcome measure was the change in the distance walked in the shuttle walk test. Secondary outcome measures were changes in symptom scores and quality of life indices. RESULTS: Objective measures of exercise tolerance did not improve significantly with Tai Chi, but patients having Tai Chi exercise had an improvement in symptom scores of heart failure measured by the Minnesota Living with Heart Failure Questionnaire (comparison of deltas, -2.4 control vs -14.9; p = 0.01), and depression scores measured by the SCL-90-R questionnaire (-2.9 vs -6.8; p = 0.12) compared with those patients in the control group. CONCLUSION: In patients with chronic heart failure, 16 weeks of Tai Chi training was safe, with no adverse exercise related problems. It was enjoyed by all taking part and led to significant improvements in symptoms and quality of life.
RCT Entities:
OBJECTIVE: To study the effect of Tai Chi on exercise tolerance in patients with moderate heart failure. DESIGN: Randomised parallel group study balanced for baseline variables. SETTING: Cardiology Department, Royal Hallamshire Hospital. PATIENTS AND METHODS: 52 patients (42 men, mean age (68.9 years), range (46-90 years), and 10 women, mean age (70.0 years), range (58-82)) with chronic heart failure (New York Heart Association symptom class II-III) were studied. Patients were randomised to Tai Chi Chuan twice a week for 16 weeks or to standard medical care without exercise rehabilitation. MAIN OUTCOME MEASURES: The primary outcome measure was the change in the distance walked in the shuttle walk test. Secondary outcome measures were changes in symptom scores and quality of life indices. RESULTS: Objective measures of exercise tolerance did not improve significantly with Tai Chi, but patients having Tai Chi exercise had an improvement in symptom scores of heart failure measured by the Minnesota Living with Heart Failure Questionnaire (comparison of deltas, -2.4 control vs -14.9; p = 0.01), and depression scores measured by the SCL-90-R questionnaire (-2.9 vs -6.8; p = 0.12) compared with those patients in the control group. CONCLUSION: In patients with chronic heart failure, 16 weeks of Tai Chi training was safe, with no adverse exercise related problems. It was enjoyed by all taking part and led to significant improvements in symptoms and quality of life.
Authors: Gloria Y Yeh; Malissa J Wood; Beverly H Lorell; Lynne W Stevenson; David M Eisenberg; Peter M Wayne; Ary L Goldberger; Roger B Davis; Russell S Phillips Journal: Am J Med Date: 2004-10-15 Impact factor: 4.965
Authors: A J Coats; S Adamopoulos; A Radaelli; A McCance; T E Meyer; L Bernardi; P L Solda; P Davey; O Ormerod; C Forfar Journal: Circulation Date: 1992-06 Impact factor: 29.690
Authors: Gloria Y Yeh; Ellen P McCarthy; Peter M Wayne; Lynne W Stevenson; Malissa J Wood; Daniel Forman; Roger B Davis; Russell S Phillips Journal: Arch Intern Med Date: 2011-04-25
Authors: Gloria Y Yeh; David H Roberts; Peter M Wayne; Roger B Davis; Mary T Quilty; Russell S Phillips Journal: Respir Care Date: 2010-11 Impact factor: 2.258
Authors: Helen Lavretsky; Lily L Alstein; Richard E Olmstead; Linda M Ercoli; Marquertie Riparetti-Brown; Natalie St Cyr; Michael R Irwin Journal: Am J Geriatr Psychiatry Date: 2011-10 Impact factor: 4.105
Authors: Laura S Redwine; Kathleen Wilson; Meredith A Pung; Kelly Chinh; Thomas Rutledge; Paul J Mills; Barbara Smith Journal: J Cardiopulm Rehabil Prev Date: 2019-11 Impact factor: 2.081
Authors: Laura S Redwine; Ming Tsuang; Anna Rusiewicz; Ines Pandzic; Stephanie Cammarata; Thomas Rutledge; Suzi Hong; Sarah Linke; Paul J Mills Journal: J Altern Complement Med Date: 2012-07-30 Impact factor: 2.579
Authors: Marilyn L Moy; Peter M Wayne; Daniel Litrownik; Douglas Beach; Elizabeth S Klings; Roger B Davis; Gloria Y Yeh Journal: Contemp Clin Trials Date: 2015-09-08 Impact factor: 2.226
Authors: Peter M Wayne; Danielle L Berkowitz; Daniel E Litrownik; Julie E Buring; Gloria Y Yeh Journal: Arch Phys Med Rehabil Date: 2014-05-27 Impact factor: 3.966